Clinical and Translational Discovery is a peer-reviewed english-language open-access journal published by Wiley in Australia, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Clinical and Translational Discovery; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Clinical and Translational Discovery has published 480 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
gene therapy, transcriptional networks, translational medicine, diagnosis
At a glance
- Publisher
- Wiley
- Country
- Australia
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2021
- Review time
- 10 weeks
- DOI prefix
10.1002- Plagiarism check
- Yes
ISSN
- electronic
- 2768-0622
Frequently asked questions
Is Clinical and Translational Discovery peer-reviewed?
Does Clinical and Translational Discovery charge an article processing charge (APC)?
What subjects does Clinical and Translational Discovery publish?
What languages does Clinical and Translational Discovery accept?
What is the ISSN of Clinical and Translational Discovery?
2768-0622 (electronic).